ENTITY
Summit Therapeutics
Summit Therapeutics
PulseAugur coverage of Summit Therapeutics — every cluster mentioning Summit Therapeutics across labs, papers, and developer communities, ranked by signal.
Total · 30d
0
1 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
0
1 over 90d
TIER MIX · 90D
TOPICS
RECENT · PAGE 1/1 · 2 TOTAL
-
Akeso's Ivonescimab Outperforms AstraZeneca's Imfinzi in Cancer Trial
Chinese biopharmaceutical company Akeso announced that its immunotherapy drug, Ivonescimab, outperformed AstraZeneca's Imfinzi in a Phase 3 trial for biliary tract cancer. This trial, involving 682 patients, is the firs…
-
Elon Musk's $158B award highlights soaring CEO pay and widening gap
Executive compensation in 2025 saw significant increases, with Elon Musk leading the pack by an extraordinary margin due to a reinstated Tesla stock award valued at $158.4 billion. Excluding Musk, median CEO compensatio…